Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Ko, P. Hebert, C. Coffey (2004)
Adverse effects of -blocker therapy for patients with heart failure: A quantitative overview of ranJournal of The American Academy of Dermatology
J. Kutner, P. Blatchford, Don Taylor, Christine Ritchie, Janet Bull, Diane Fairclough, Laura Hanson, Thomas LeBlanc, Greg Samsa, S. Wolf, Noreen Aziz, D. Currow, B. Ferrell, N. Wagner-Johnston, S. Zafar, James Cleary, Sandesh Dev, Patricia Goode, Arif Kamal, C. Kassner, Elizabeth Kvale, Janelle McCallum, Adeboye Ogunseitan, S. Pantilat, Russell Portenoy, Maryjo Prince-Paul, Jeff Sloan, K. Swetz, C. Gunten, A. Abernethy (2015)
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.JAMA internal medicine, 175 5
A. Foebel, R. Liperoti, G. Gambassi, J. Gindin, Joshua Israel, R. Bernabei, G. Onder (2014)
Prevalence and correlates of cardiovascular medication use among nursing home residents with ischemic heart disease: results from the SHELTER study.Journal of the American Medical Directors Association, 15 6
S. Rathore, R. Mehta, Yongfei Wang, M. Radford, H. Krumholz (2003)
Effects of age on the quality of care provided to older patients with acute myocardial infarction.The American journal of medicine, 114 4
MA Steinman, AR Zullo, Y Lee
Association of ?-blockers with functional outcomes, death, and rehospitalization in older nursing home residents after acute myocardial infarction [published online December 12, 2016]
T. Fried, M. Tinetti, Joe Agostini, L. Iannone, V. Towle (2011)
Health outcome prioritization to elicit preferences of older persons with multiple health conditions.Patient education and counseling, 83 2
E. Amsterdam (2015)
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Terri Fried, S. McGraw, Joseph Agostini, M. Tinetti (2008)
Views of Older Persons with Multiple Morbidities on Competing Outcomes and Clinical Decision‐MakingJournal of the American Geriatrics Society, 56
Anna Kezerashvili, K. Marzo, Joshua Leon (2012)
Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?Current Cardiology Reviews, 8
EA Amsterdam, NK Wenger, RG Brindis (2014)
2014 AHA/ACC guideline for the management of patients with non?ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, 64
S. Bangalore, F. Messerli, Jerome Cohen, P. Bacher, P. Sleight, G. Mancia, P. Kowey, Qian Zhou, Annette Champion, C. Pepine (2008)
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.American heart journal, 156 2
Hyerim Park, H. Satoh, A. Miki, H. Urushihara, Y. Sawada (2015)
Medications associated with falls in older people: systematic review of publications from a recent 5-year periodEuropean Journal of Clinical Pharmacology, 71
I. Scott, S. Hilmer, E. Reeve, K. Potter, D. Couteur, Deborah Rigby, D. Gnjidic, C. Mar, E. Roughead, A. Page, J. Jansen, Jennifer Martin (2015)
Reducing inappropriate polypharmacy: the process of deprescribing.JAMA internal medicine, 175 5
PT O’Gara, FG Kushner, DD Ascheim (2013)
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed, 62
(2016)
Association of β-blockers with functional outcomes, death, and rehospitalization in older nursing home residents after acute myocardial infarction
E. Antman, D. Anbe, P. Armstrong, Eric Bates, L. Green, M. Hand, J. Hochman, H. Krumholz, F. Kushner, G. Lamas, C. Mullany, J. Ornato, D. Pearle, M. Sloan, Sidney Smith (2004)
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients WiThe Canadian journal of cardiology, 20 10
American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions
A. Barron, Nabeela Zaman, G. Cole, R. Wensel, D. Okonko, D. Francis (2013)
Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient information☆☆☆International Journal of Cardiology, 168
H. Holmes, D. Hayley, G. Alexander, G. Sachs (2006)
Reconsidering medication appropriateness for patients late in life.Archives of internal medicine, 166 6
(1999)
Divergent effects of β - blocker therapy on self - estimated and objectively scored activities of daily living
Research Original Investigation Association of β-Blockers With Functional Outcomes After Acute Myocardial Infarction community-dwelling older men: a population- 42. Kamiyama T, Muratani H, Kimura Y, Fukiyama K, 46. Fried TR, Tinetti M, Agostini J, Iannone L, based study. Int J Cardiol. 2015;192:49-55. Omae T. Divergent effects of β-blocker therapy on Towle V. Health outcome prioritization to elicit self-estimated and objectively scored activities of preferences of older persons with multiple health 39. Ko DT, Hebert PR, Coffey CS, et al. Adverse daily living. Hypertens Res. 1999;22(2):85-93. conditions. Patient Educ Couns. 2011;83(2):278-282. effects of β-blocker therapy for patients with heart failure: a quantitative overview of randomized 43. Park H, Satoh H, Miki A, Urushihara H, Sawada 47. Centers for Medicare & Medicaid Services. trials. Arch Intern Med. 2004;164(13):1389-1394. Y. Medications associated with falls in older people: Nursing Home Data Compendium 2015 Edition. https: systematic review of publications from a recent //www.cms.gov/Medicare/Provider-Enrollment-and- 40. Barron AJ, Zaman N, Cole GD, Wensel R, 5-year period. Eur J Clin Pharmacol. 2015;71(12): Certification/CertificationandComplianc/Downloads Okonko DO, Francis DP. Systematic review of 1429-1440. /nursinghomedatacompendium_508-2015.pdf. genuine versus spurious side-effects of β-blockers Published 2015. Accessed July 14, 2016. in heart failure using placebo control: 44. Foebel AD, Liperoti R, Gambassi
JAMA Internal Medicine – American Medical Association
Published: Feb 12, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.